Colossal Biosciences
An American biotechnology company focused on de-extinction research. The company uses gene-editing tools to revive extinct species, including the woolly mammoth, dire wolf, and dodo bird, while also developing technologies for the conservation of existing endangered species.
Timeline (last 90 days)
Colossal Biosciences' de-extinction technology is still at the proof-of-concept stage.
Warhound is jointly promoted by Colossal Biosciences founder Ben Lamm and Anduril founder Palmer Luckey.
Colossal Biosciences is a biotechnology company founded by Ben Lamm, known for its "de-extinction" projects that attempt to revive extinct species such as the woolly mammoth and the dodo through gene-editing technologies such as CRISPR.
Biotech company Colossal Biosciences announced last week the launch of a brand-new AI platform aimed at accelerating its de-extinction research process, helping research teams more efficiently analyze genetic data, simulate species reconstruction pathways and optimize experimental workflows.
Colossal Biosciences was founded by Ben Lamm and George Church, with the core goal of using CRISPR gene editing, stem cell technology and synthetic biology methods to bring extinct species back to Earth.
Colossal Biosciences' previously publicly announced flagship projects include the woolly mammoth, the thylacine (Tasmanian tiger) and the dodo.
Beth Shapiro is the Chief Science Officer of Colossal Biosciences, an evolutionary biologist, and a former Howard Hughes Medical Institute investigator.
The dire wolf reconstruction project involved a total of 20 selected gene edits.
The dire wolf project reconstructs the dire wolf by extracting and sequencing the genome from dire wolf fossils, identifying the genetic changes that made dire wolves larger, stronger, and lighter in coat color, and engineering those changes into the gray wolf genome.
Colossal is developing artificial womb technology to enable the simultaneous gestation of hundreds of mammoths without occupying the 22-month gestation period of Asian elephants.
2 more timeline events
All Facts (11)
Colossal Biosciences' de-extinction technology is still at the proof-of-concept stage.
50%UnverifiedWarhound is jointly promoted by Colossal Biosciences founder Ben Lamm and Anduril founder Palmer Luckey.
50%UnverifiedColossal Biosciences is a biotechnology company founded by Ben Lamm, known for its "de-extinction" projects that attempt to revive extinct species such as the woolly mammoth and the dodo through gene-editing technologies such as CRISPR.
50%UnverifiedColossal Biosciences was founded by Ben Lamm and George Church, with the core goal of using CRISPR gene editing, stem cell technology and synthetic biology methods to bring extinct species back to Earth.
50%UnverifiedColossal Biosciences' previously publicly announced flagship projects include the woolly mammoth, the thylacine (Tasmanian tiger) and the dodo.
50%UnverifiedBeth Shapiro is the Chief Science Officer of Colossal Biosciences, an evolutionary biologist, and a former Howard Hughes Medical Institute investigator.
50%UnverifiedNorthern Australian quolls die from the toxic invasive species cane toad, and Colossal's Australian partners have enabled quolls to eat cane toads without dying by changing a single base in a single gene.
50%UnverifiedThe dire wolf project reconstructs the dire wolf by extracting and sequencing the genome from dire wolf fossils, identifying the genetic changes that made dire wolves larger, stronger, and lighter in coat color, and engineering those changes into the gray wolf genome.
50%UnverifiedThe dire wolf reconstruction project involved a total of 20 selected gene edits.
50%UnverifiedColossal is developing artificial womb technology to enable the simultaneous gestation of hundreds of mammoths without occupying the 22-month gestation period of Asian elephants.
50%UnverifiedColossal announced the results of cloning red wolves, introducing new genetic diversity into the existing red wolf population by cloning coyote-like animals carrying more than 75% red wolf ancestry.
50%